Asset Dedication LLC’s CareDx CDNA Stock Holding History

Asset Dedication LLC’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-270	Closed	-$8K	–	593
2018 Q3	$8K	Sell	270 -658	-71%	-$12.3K	﹤0.01%	463
2018 Q2	$11K	Buy	+928	New	+$10.6K	﹤0.01%	431

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Asset Dedication LLC's CDNA Position: Q4 2018 in Review

Asset Dedication LLC sold out of CareDx (CDNA) in Q4 2018, closing a stake of 270 shares — an estimated $8K sold.

Asset Dedication LLC first reported a position in CDNA in Q2 2018 and held it in 2 quarters. The position peaked at $11K in Q2 2018. 148 funds tracked by Wall St. Rank hold CDNA as of Q4 2018.

Asset Dedication LLC reported no remaining CareDx position as of Q4 2018 after selling out during the quarter.
Asset Dedication LLC sold 270 CareDx shares in Q4 2018, an estimated $8K.
Asset Dedication LLC first reported a position in CareDx in Q2 2018 and held it in 2 quarters.
Asset Dedication LLC's CareDx position peaked at $11K in Q2 2018.
148 funds tracked by Wall St. Rank held CareDx as of Q4 2018.

Based on Asset Dedication LLC's 13F filing for Q4 2018, filed 12 Feb 2019.